The value of an infectious diseases specialist

被引:91
作者
Petrak, RM
Sexton, DJ
Butera, ML
Tenenbaum, MJ
MacGregor, MC
Schmidt, ME
Joseph, WP
Kemmerly, SA
Dougherty, MJ
Bakken, JS
Curfman, MF
Martinelli, LP
Gainer, RB
机构
[1] Metro Infect Dis Consultants, Hinsdale, IL 60521 USA
[2] Travel Med Source, Morton Grove, IL USA
[3] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC USA
[4] ID Assoc Calif, San Diego, CA USA
[5] ID Med Grp, San Ramon, CA USA
[6] ID Consultants, Port Washington, NY USA
[7] ID Consultants, Fairfax, VA USA
[8] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA
[9] Lexington ID Consultants, Lexington, KY USA
[10] Duluth Clin, Duluth, MN USA
[11] Ft Wayne ID, Ft Wayne, IN USA
[12] Lubbock ID Consultants, Lubbock, TX USA
[13] Morgantown Internal Med Grp, Morgantown, WV USA
关键词
D O I
10.1086/374245
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infectious diseases (ID) specialists have played a major role in patient care, infection control, and antibiotic management for many years. With the rapidly changing nature of health care, it has become necessary for ID specialists to articulate their value to multiple audiences. This article summarizes the versatile attributes possessed by ID specialists and delineates their value to patients, hospitals, and other integral groups in the health care continuum.
引用
收藏
页码:1013 / 1017
页数:5
相关论文
共 46 条
[1]   Protein C replacement in severe meningococcemia:: Rationale and clinical experience [J].
Alberio, L ;
Lämmle, B ;
Esmon, CT .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1338-1346
[2]  
BALINSKY W, 1989, AM J MED, V87, P301, DOI 10.1016/S0002-9343(89)80155-X
[3]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[4]   ANTIBIOTIC STREAMLINING FROM COMBINATION THERAPY TO MONOTHERAPY UTILIZING AN INTERDISCIPLINARY APPROACH [J].
BRICELAND, LL ;
NIGHTINGALE, CH ;
QUINTILIANI, R ;
COOPER, BW ;
SMITH, KS .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (09) :2019-2022
[5]   Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia [J].
Byl, B ;
Clevenbergh, P ;
Jacobs, F ;
Struelens, MJ ;
Zech, F ;
Kentos, A ;
Thys, JP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :60-66
[6]   Infectious diseases consultation: Impact on outcomes for hospitalized patients and results of a preliminary study [J].
Classen, DC ;
Burke, JP ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) :468-470
[7]  
COTTON MF, 1995, PEDIATRICS, V95, P753
[8]  
Deery HG, 1997, INFECT CONT HOSP EP, V18, P209
[9]   CLINICAL IMPACT OF RAPID IN-VITRO SUSCEPTIBILITY TESTING AND BACTERIAL IDENTIFICATION [J].
DOERN, GV ;
VAUTOUR, R ;
GAUDET, M ;
LEVY, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (07) :1757-1762
[10]   Making the business case for infection control: Pitfalls and opportunities [J].
Dunagan, WC ;
Murphy, DM ;
Hollenbeak, CS ;
Miller, SB .
AMERICAN JOURNAL OF INFECTION CONTROL, 2002, 30 (02) :86-92